Even more troubling, research demonstrates that discontinuing GLP-1 receptor agonist treatment leads to significant weight regain, with patients taking liraglutide regaining an average of 2.20 kg and those on semaglutide or tirzepatide regaining 9.69 kg
The demand for glutathione injection before and after transformations is growing rapidly, with salons and unlicensed clinics offering shady treatments without proper knowledge of the side effects
In the United States, a combination product containing topiramate and phentermine (Qsymia) is approved for obesity management, but this combination is not licensed by the MHRA for use in the UK
Ozempic Face: What It Is and How To Avoid It
Will compounded semaglutide work as well as Ozempic or Wegovy
Available online at: Summary Keywords weight loss, nutrient intake, glucagon-like peptide-1 receptor agonists, nutrition, diet, dietary reference intakes Citation Johnson B, Milstead M, Thomas O, McGlasson T, Green L, Kreider R and Jones R (2025) Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study